Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Sharp Edge Labs logo — Advancing cellular biology research with innovative biosenso...

Sharp Edge Labs

Advancing cellular biology research with innovative biosensor technology for precise, high-throughput screening since 2011. Based in Pittsburgh, Pennsylvania.

Founded 2010 2-10 employees Venture round Total: $4.60M Biotechnology, Life Sciences +1

General Information

Company Name Sharp Edge Labs
Founded Year 2010
Founders / Decision Makers
Team member
Employees 2-10
Industries Biotechnology, Life Sciences, Medical Devices
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Sharp Edge Labs. To contact Sharp Edge Labs, visit sharpedgelabs.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Sharp Edge Labs compare?

A PDF of Sharp Edge Labs and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Sharp Edge Labs soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Sharp Edge Labs

Sharp Edge Labs is a biotechnology startup that has been advancing cellular biology research since 2011. Based in Pittsburgh, Pennsylvania, the company specializes in innovative biosensor technology for precise, high-throughput screening. Utilizing fluorogenic activating proteins, Sharp Edge Labs offers a range of specialized biosensors designed for the cellular biology research sector. These biosensors provide a method for detecting cellular changes suitable for high-throughput screening and subsequent analysis. Founded in 2011, Sharp Edge Labs has garnered attention within the industries of biotechnology, life sciences, and medical devices. Notably, the company received a $3.55M Venture Round investment on 08 August 2019. Despite the absence of disclosed investors, this investment underscores the market's confidence in the potential of Sharp Edge Labs and their innovative biosensor technology.

Business keywords: Biosensors, Cellular Biology Research, High-throughput Screening, Fluorogenic Activating Proteins, Drug Discovery, Genetic Diseases, Life Sciences, Innovation, Research and Development, Pittsburgh, Pennsylvania, Start-up, Investment, Technology

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $3.55M -
08 Aug 2019
Series C Undisclosed 1
Innovation Works
Innovation Works
30 Jun 2017
Convertible Note Undisclosed 1
Innovation Works
Innovation Works
03 Sep 2016
Series B $600.00K 2
Innovation Works Newlin Investment Company
Innovation Works, Newlin Investment Company
19 Aug 2014
Venture Round $100.00K -
10 Jan 2014
Seed Round $250.00K -
09 Jul 2013
Seed Round $100.00K -
05 Jan 2012

Sharp Edge Labs Alternatives & Competitors

View All Alternatives
Sharp Edge Labs vs
Axxam
Axxam Italy

Translating innovative biology into bioactive molecules

Grant
197 employees
Biotechnology, Medical Devices
Sharp Edge Labs vs
TRELYS
TRELYS

Driving innovation in biotechnology since 2012 with roots in San Francisco, California

Seed
Biotechnology, Life Sciences
Sharp Edge Labs vs
KTK BIOTECH
KTK BIOTECH Turkey

Episozyme

1 employees
Biotechnology, Life Sciences
View all alternatives

FAQ About Sharp Edge Labs

Advancing cellular biology research with innovative biosensor technology for precise, high-throughput screening since 2011. Based in Pittsburgh, Pennsylvania.
Sharp Edge Labs was founded in 2010.
Sharp Edge Labs operates in Biotechnology, Life Sciences and Medical Devices. Its work centres on Biosensors, Cellular Biology Research, High-throughput Screening and Fluorogenic Activating Proteins.
Sharp Edge Labs has approximately 2-10 employees.
Sharp Edge Labs has completed 7 funding rounds, raising a total of $4.60M. The latest funding stage is Venture round.
Top alternatives and competitors to Sharp Edge Labs include Axxam, TRELYS, KTK BIOTECH , Atrandi Biosciences, Mekonos Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sharp Edge Labs and Axxam are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Sharp Edge Labs, https://bouncewatch.com/company/sharp-edge-labs, updated 20 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes